Article Details

Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Stem Cell Research

Retrieved on: 2025-08-30 13:01:44

Tags for this article:

Click the tags to see associated articles and topics

Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Stem Cell Research. View article details on hiswai:

Excerpt

Propanc Biopharma, Inc. (NASDAQ: PPCB) has successfully closed a $4 million underwritten public offering, selling 1,000,000 shares of common stock ...

Article found on: www.citybuzz.co

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo